PLoS ONE (Jan 2022)

Parents' views on accepting, declining, and expanding newborn bloodspot screening.

  • Sylvia M van der Pal,
  • Sophie Wins,
  • Jasmijn E Klapwijk,
  • Tessa van Dijk,
  • Adriana Kater-Kuipers,
  • Catharina P B van der Ploeg,
  • Suze M P J Jans,
  • Stephan Kemp,
  • Rendelien K Verschoof-Puite,
  • Lion J M van den Bosch,
  • Lidewij Henneman

DOI
https://doi.org/10.1371/journal.pone.0272585
Journal volume & issue
Vol. 17, no. 8
p. e0272585

Abstract

Read online

IntroductionThe goal of newborn bloodspot screening (NBS) is the early detection of treatable disorders in newborns to offer early intervention. Worldwide, the number of conditions screened for is expanding, which might affect public acceptance. In the Netherlands, participation is high (>99%), but little is known about how parents perceive NBS. This study assessed parents' views on accepting, declining and expanding NBS.MethodsA total of 804 of 6051 (13%) invited parents who participated in NBS in the Netherlands during the last two weeks of December 2019, and 48 of 1162 (4%) invited parents who declined participation in NBS in 2019 and 2020, completed a questionnaire.ResultsThe most important reason for parents to participate in NBS was to prevent health complaints, whereas the most important reason to decline NBS was parents' viewpoint on life and the belief that the heel prick would be painful for the child. Compared to NBS participants, respondents who declined NBS were more actively religious, considered alternative medicine or lifestyle more important, were less inclined to vaccinate their child for infectious diseases, and reported more doubt about NBS participation (all differences p ConclusionMost participants made an informed decision to participate in NBS and are positive about screening for more conditions. Insights into parents' views on (non-)participation and expansion of NBS can help to ensure that NBS suits the population needs while safeguarding ethical principles for screening.